BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7735007)

  • 1. Evaluation of immunosuppressive acidic protein in human ovarian cancer.
    Lin YH; Chow SN; Chen CK; Chen RJ; Huang SC; Huang GT
    J Formos Med Assoc; 1994 Sep; 93(9):776-80. PubMed ID: 7735007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunosuppressive acidic protein in patients with gynecologic cancer].
    Sawada M; Matsui Y; Okudaira Y; Shimizu Y; Takayama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):605-11. PubMed ID: 6408203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive acidic protein in patients with ovarian cancer.
    Sawada M; Okudaira Y; Matsui Y; Shimizu Y
    Cancer; 1983 Dec; 52(11):2081-5. PubMed ID: 6627216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Variations in the level of immunosuppressive acidic protein in patients with gynecologic tumors and pregnant women].
    Sawada M; Okudaira Y; Matsui Y; Miyoshi Y; Takayama K; Shimizu Y; Miura S
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1823-30. PubMed ID: 6882005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive acidic protein in patients with gynecologic cancer.
    Sawada M; Okudaira Y; Matsui Y; Shimizu Y
    Cancer; 1984 Aug; 54(4):652-6. PubMed ID: 6744202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive acidic protein and CA 125 levels in patients with ovarian cancer.
    Castelli M; Battaglia F; Scambia G; Panici PB; Ferrandina G; Mileo AM; Mancuso S; Ferrini U
    Oncology; 1991; 48(1):13-7. PubMed ID: 1987493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of immunosuppressive acidic protein in the diagnosis and follow-up of patients with ovarian cancer, in particular as a marker for chemotherapeutic effects].
    Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y; Kurachi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Apr; 38(4):554-60. PubMed ID: 3701144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of immunosuppressive acidic protein (IAP), CA 125 and acute-phase proteins as parameters for ovarian cancer monitoring.
    Koebl H; Tatra G; Bieglmayer C
    Neoplasma; 1988; 35(2):215-20. PubMed ID: 3259680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive acidic protein (IAP) and CA 125 assays in detection of human ovarian cancer: preliminary results.
    Castelli M; Romano P; Atlante G; Pozzi M; Ferrini U
    Int J Biol Markers; 1987; 2(3):187-90. PubMed ID: 3482661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on immunosuppressive acidic protein (IAP) in ovarian tumors].
    Miyoshi T; Nishimura H; Hamai J; Yamada T; Tomoo Y; Kobayashi H; Yakushiji M; Kato T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):923-9. PubMed ID: 2991397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive substance in the sera of head and neck cancer patients.
    Yamanaka N; Harabuchi Y; Himi T; Kataura A
    Cancer; 1988 Oct; 62(7):1293-8. PubMed ID: 3416271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
    Sakita M; Yamane T; Kasuga M; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1755-64. PubMed ID: 7184372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum level of immunosuppressive acidic protein in patients with urological malignancies.
    Pu YS; Tsai TC; Chiu TY; Hsieh TS; Chen J; Chen SC; Lin MC; Hsu TC
    J Formos Med Assoc; 1991 May; 90(5):498-503. PubMed ID: 1680990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum levels of immunosuppressive acidic protein in gynecological cancer].
    Sato S; Wakisaka T; Hamazaki Y; Oikawa N; Toki T; Yamauchi R; Sakahira H; Tase T; Yajima A; Suzuki M
    Gan No Rinsho; 1983 Jul; 29(8):897-9. PubMed ID: 6887522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of serum immunosuppresive acidic protein levels in gynecological tumor].
    Zhang W; Wang P; Zhao Y
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):194-6. PubMed ID: 11601039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive acidic protein (IAP) and squamous cell carcinoma antigen (SCC) in patients with cervical cancer.
    Battaglia F; Scambia G; Panici PB; Castelli M; Ferrandina G; Foti E; Amoroso M; D'Andrea G; Mancuso S
    Gynecol Oncol; 1994 May; 53(2):176-82. PubMed ID: 8188076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK.
    Sakamoto J; Koike A; Saji S; Teramukai S; Ohashi Y; Nakazato H
    Surg Today; 1992; 22(6):530-6. PubMed ID: 1472793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive acidic protein serum levels in breast cancer patients in a reference to CA 15-3 levels.
    Cohen AD; Shoenfeld Y; Gopas J; Cohen Y
    Breast Cancer Res Treat; 1994; 30(2):197-200. PubMed ID: 7949217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ["Immunosuppressive acidic protein" (IAP)--an improvement for tumor marker diagnosis in epithelial ovarian cancer?].
    Sevelda P; Haider F; Spona J
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):452-5. PubMed ID: 3476335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on serum levels of immunosuppressive acidic protein (IAP) as a marker of renal cell carcinoma].
    Hoshino M; Fuji K; Kataoka K; Inoue K; Higaki Y; Imamura K
    Hinyokika Kiyo; 1989 Oct; 35(10):1647-52. PubMed ID: 2610170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.